Nortech Systems Inc. (NSYS) - 10-K Summary
Business Context and Reporting Period
Company: Nortech Systems Incorporated
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2025
Business Overview: Nortech is a global Electronic Manufacturing Services (EMS) provider specializing in complex electromedical devices, electromechanical systems, and assemblies. Operations are conducted in Minnesota (USA), Monterrey (Mexico), and Suzhou (China). The company serves Medical Device, Medical Imaging, Aerospace & Defense, and Industrial markets, with over 50% of net sales derived from medical-related sectors.
Key Financial Metrics (Year Ended Dec 31, 2025)
| Metric | 2025 (in thousands) | 2024 (in thousands) |
|---|---|---|
| Net Sales | $118,365 | $128,133 |
| Gross Profit | $18,006 | $16,722 |
| Gross Margin | 15.2% | 13.1% |
| Operating Income | $975 | $(195) |
| Net Loss | $(252) | $(1,295) |
| Diluted EPS | $(0.09) | $(0.47) |
| Operating Cash Flow | $2,743 | $(2,250) |
| Total Debt (Line of Credit) | $7,000 | $8,695 |
| Cash and Equivalents | $1,655 | $916 |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 7.6% to $118.4 million. Significant declines occurred in Aerospace & Defense (-24.4%) and Industrial (-12.9%) segments due to customer order delays, part shortages, and facility consolidation impacts. Medical Imaging sales increased 6.7%.
- Margin Expansion: Gross margin improved by 210 basis points to 15.2%, driven by improved plant utilization from restructuring and favorable sales mix.
- Profitability Turnaround: The company returned to operating profitability ($0.975 million) from an operating loss in 2024, primarily due to margin improvements and lower incentive compensation accruals.
- Restructuring: Restructuring charges decreased 53.4% to $0.266 million, reflecting the completion of the Blue Earth facility closure and a reduction in force in early 2025.
- Backlog Growth: Total order backlog increased 17.4% to $77.3 million, indicating strong future demand despite current revenue headwinds.
Outlook, Risks, and Contingencies
- Financing Restructuring: The company faced covenant compliance issues with its Bank of America facility in 2024 and 2025, requiring multiple waivers. On March 20, 2026 (subsequent to year-end), Nortech repaid the BOA facility and entered a new Credit and Security Agreement with Associated Bank for up to $15.0 million revolving and a $2.2 million term loan, maturing in 2029.
- Customer Concentration: One customer accounted for 32.2% of net sales in 2025 (up from 27.7% in 2024). Loss of this customer would materially impact operations.
- Supply Chain & Tariffs: Risks include component shortages and potential cost increases. A subsequent event notes new temporary global tariffs (10%) effective February 2026, which the company is evaluating for impact on material costs.
- Regulatory Compliance: The company maintains FDA, ISO, and AS9100 certifications. It achieved CMMC Level 2 certification in October 2025, essential for defense contracts.
- Foreign Operations: Operations in Mexico and China expose the company to currency fluctuations and regulatory risks, including delays in Mexican VAT refunds.
Investor Verification Checklist
- Covenant Compliance: Verify the company's ability to meet the Fixed Charge Coverage Ratio (1.10:1.00) under the new Associated Bank facility.
- Customer Concentration: Monitor the stability of the top customer representing 32.2% of revenue.
- Tariff Impact: Assess the financial impact of the new 10% global tariffs announced in February 2026 on cost of goods sold.
- Backlog Conversion: Track the conversion rate of the $77.3 million backlog into recognized revenue in 2026.
- Working Capital: Review accounts receivable aging and inventory reserves ($1.853 million) given the history of customer order changes.